Immunotherapy efficacy up with Gal-1/SIT co-administration
(HealthDay)—Galectin-1 (Gal-1), allergen-specific immunotherapy (SIT) co-administration may suppress allergic responses in the intestine more than use of SIT or Gal-1 alone, according to an experimental study published ...
Jul 24, 2017
0
0